🤖 The First Prototype of Mysterious AI Hardware

📦The First Prototype of Mysterious AI Hardware

🪡AI Finds the Genetic Needle in the Human Haystack

🛠Trending Tools

🥪Brief Bites

💰Funding Frontlines

💼Who’s Hiring?

Earlier this year, OpenAI acquired io Products, Inc. for nearly $6.5 billion, gaining legendary Apple designer Jony Ive and his hand-picked team of 55 designers, architects, and engineers.

OpenAI CEO Sam Altman explained: “When people see it, they say, ‘That’s it?… It’s so simple.’” Little is known about the secretive AI-powered gadget, though it’s rumored to be screenless and palm-sized to promote less socially disruptive experiences.

iyO also recently sued OpenAI, alleging they met with them to discuss their in-ear technology, even demoing the “iyO One”: earbuds designed to be the world’s first audio computer. This lawsuit forced OpenAI to disclose that the secretive AI-powered gadget relies solely on audio and visual cues.

For the past two decades, our digital lives have been dominated by typing, tapping, and touching. Now, the hands-free era is emerging, where technology is built around voice controls and touchless navigation.

So, what changed?! Not only did speech recognition stop being terrible, but LLMs made talking to technology feel realistic. For example, ChatGPT’s Advanced Voice Mode actually feels like you’re interacting with a real human.

Our DNA contains sequences of billions of “letters,” which tell our body how to grow and heal. These sequences are a specific order of the four Nucleotides: Adenine {A}, Thymine {T}, Cytosine {C}, and Guanine {G}.

For example, a small piece of DNA might look like this: {ATCGTACG}. The order of these “letters” matters a lot. Even a minor change can affect how our body functions. Only about 2% of our DNA actually contains genes that tell our body how to build tissues and fight infections.

Every human has tens of thousands of tiny genetic alterations in that 2% of DNA, also known as variants, that affect how we respond to illness. “PopEVE” sorts through these variants and identifies those most likely to cause disease, helping distinguish between common genetic alterations and rare genetic conditions that cause serious health problems.

When tested on a cohort of around 30,000 patients with severe developmental disorders who hadn’t received a diagnosis, “PopEVE” uncovered previously unidentified variants in about one-third of cases.

400 million people worldwide are affected by rare genetic diseases, representing about 5.9% of the global population. More specifically, around 80% of rare diseases have a genetic cause.

AI One landed a $7M Series A to activate the context of your enterprise.

Tailor raised a $37M Series A to handle all the backend business stuff.

xAI to close a $15B Series E to advance our knowledge of the universe.

Skydio (San Mateo, CA): Cloud Software Engineer Intern, Summer 2026

Cohere (Remote): AI Data Trainer, English Language, Entry-Level

Databricks (Mountain View, CA): Product Operation Analyst, Mid-Level

Hive (San Francisco, CA): Sr. Backend Software Engineer, Senior-Level